Related Experiment Video
Updated: Jul 14, 2026

06:26
Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
[Absorbable coronary stents. New promising technology]
Raimund Erbel1, Dirk Böse, Michael Haude
1Klinik für Kardiologie, Westdeutsches Herzzentrum Essen, Universitätsklinikum Essen, Universität Duisburg-Essen, Hufelandstrasse 55, 45122, Essen. erbel@uk-essen.de
Herz
|July 4, 2007
Summary
Absorbable magnesium stents offer a promising alternative to permanent coronary implants. These temporary stents degrade over time, enabling future procedures and restoring natural vessel function.
Area of Science:
- Cardiovascular medicine
- Biomaterials science
- Interventional cardiology
Context:
- Coronary stent implantation is a standard procedure, but permanent implants limit future interventions.
- Research is ongoing for temporary stenting solutions, including absorbable polymer and metal stents.
- Magnesium stents represent a novel approach to temporary coronary stenting.
Purpose:
- To evaluate the safety and efficacy of an absorbable magnesium stent in coronary arteries.
- To assess the degradation process and impact on vasomotion.
- To determine the feasibility of noninvasive imaging post-implantation.
Summary:
- The absorbable magnesium stent demonstrated low recoil and strut absorption, confirmed by intravascular ultrasound (IVUS).
- The stent was invisible to standard imaging modalities like CT and MRI, allowing for noninvasive follow-up.
- The study met its primary endpoint, showing a low ischemia-driven target lesion revascularization rate and restoration of vasomotion.
Impact:
- Avoids permanent foreign-body implantation, facilitating future revascularization and bypass grafting.
- Enables noninvasive imaging of coronary arteries using CT and MRI.
- Opens possibilities for prophylactic stenting and pediatric applications.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
